Russell J A, Luider J, Weaver M, Brown C, Selinger S, Railton C, Karlsson L, Klassen J
Alberta Bone Marrow Transplant Program, Foothills Hospital, Calgary, Alberta, Canada.
Bone Marrow Transplant. 1995 Jan;15(1):111-5.
Fourteen donors were given recombinant G-CSF to mobilize progenitor cells. Circulating CD34+ cells were monitored daily and leukapheresis was performed at 3-5 days when the level exceeded 20 x 10(6)/L. Monitoring of CD34+ cells collected at intervals during apheresis gave results within 20 min. Yields of 2.6-7.4 x 10(6) per kg recipient body weight were achieved in single aphereses of 2-4 h in all but two cases where the donor was substantially smaller than the recipient. These products were sufficient to establish engraftment, at least of granulocytes, in 11 five or six antigen matched recipients with high risk malignancy. Despite some complications donors tolerated the procedure well and the five individuals who had previously given marrow preferred these manoeuvres to bone marrow harvest. The ability to monitor CD34+ cells rapidly in the circulation and leukapheresis product facilitates an efficient collection technique for allogeneic BCT donors. Adequate yields could probably be achieved by a single harvest on days 2-4 in most donors.
14名供者接受重组人粒细胞集落刺激因子(G-CSF)以动员祖细胞。每天监测循环中的CD34+细胞,当该水平超过20×10⁶/L时,在3 - 5天进行白细胞分离术。在白细胞分离术期间定期收集的CD34+细胞监测结果在20分钟内得出。除了两名供者明显小于受者的情况外,在2 - 4小时的单次白细胞分离术中,每千克受者体重可获得2.6 - 7.4×10⁶的产量。这些产物足以使11名患有高风险恶性肿瘤且有5或6个抗原匹配的受者至少植入粒细胞。尽管有一些并发症,但供者对该程序耐受性良好,5名以前捐献过骨髓的个体更喜欢这些操作而不是骨髓采集。能够快速监测循环中和白细胞分离产物中的CD34+细胞,有助于为异基因骨髓移植供者建立一种有效的采集技术。大多数供者可能在第2 - 4天通过单次采集获得足够的产量。